Stay updated on Belantamab Mafodotin Combo in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Belantamab Mafodotin Combo in Myeloma Clinical Trial page.

Latest updates to the Belantamab Mafodotin Combo in Myeloma Clinical Trial page
- Check3 days agoChange DetectedThe record history gains a new release note label 'Revision: v3.6.3' and an additional item 'Results Submission Events (1)', indicating a platform update to the history data.SummaryDifference0.2%

- Check10 days agoChange DetectedThe study history now includes a new revision entry (v3.6.2) and the previous revision (v3.6.0) was removed from the history, reflecting an update to the record's release history.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedAdded the statement 'No longer looking for participants' to indicate that recruitment has ended. Updated the revision history to 'Revision: v3.6.0' and removed the previous 'Revision: v3.5.5' entry.SummaryDifference0.3%

- Check31 days agoChange DetectedVersion 3.5.5 is added with Results Submitted, replacing No Results Posted in the history; the history now reflects that trial results have been submitted.SummaryDifference0.1%

- Check52 days agoChange DetectedA new revision entry (v3.5.4) was added to the record history, and the previous entry (v3.5.3) was removed. This reflects a minor site release updating the history metadata.SummaryDifference0.1%

- Check74 days agoChange DetectedUpdates the displayed revision/version label from v3.5.2 to v3.5.3 for the page experience.SummaryDifference0.1%

Stay in the know with updates to Belantamab Mafodotin Combo in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belantamab Mafodotin Combo in Myeloma Clinical Trial page.